Péter Kótay Nagy

Title: Innovations of Inventor Péter Kótay Nagy

Introduction

Péter Kótay Nagy is a notable inventor based in Vác, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new crystalline forms of drugs. With a total of five patents to his name, his work has the potential to impact the treatment of various psychotic conditions.

Latest Patents

One of his latest patents is focused on the polymorphs of olanzapine hydrochloride. This invention relates to new crystalline forms I, II, and III of 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]-benzodiazepine hydrochloride. The patent outlines a process for the preparation of these forms and pharmaceutical compositions containing them. These new polymorphic forms are particularly useful as active ingredients for treating psychotic conditions. Another significant patent involves a process for the preparation of an amorphous form of a platelet aggregation inhibitor drug. This invention describes a new method for preparing the polymorph form 1 of methyl (S)-(+)-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridine-5-yl-acetate hydrogensulfate.

Career Highlights

Throughout his career, Péter Kótay Nagy has worked with prominent companies in the pharmaceutical industry, including Egis Gyógyszergyár Rt. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Péter has collaborated with notable colleagues such as József Barkóczy and Gyula Simig. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Péter Kótay Nagy is a distinguished inventor whose work in pharmaceuticals has led to the development of innovative drug formulations. His contributions are essential for advancing treatments for psychotic conditions and improving patient outcomes.